| Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA–induced dyskinesia and the role of dopamine D1 receptors JE Westin, L Vercammen, EM Strome, C Konradi, MA Cenci Biological psychiatry 62 (7), 800-810, 2007 | 313 | 2007 |
| Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia C Konradi, JE Westin, M Carta, ME Eaton, K Kuter, A Dekundy, ... Neurobiology of disease 17 (2), 219-236, 2004 | 174 | 2004 |
| Persistent changes in striatal gene expression induced by long‐term l‐DOPA treatment in a rat model of Parkinson's disease JE Westin, M Andersson, M Lundblad, MA Cenci European journal of neuroscience 14 (7), 1171-1176, 2001 | 160 | 2001 |
| Endothelial proliferation and increased blood–brain barrier permeability in the basal ganglia in a rat model of 3, 4-dihydroxyphenyl-L-alanine-induced dyskinesia JE Westin, HS Lindgren, J Gardi, JR Nyengaard, P Brundin, P Mohapel, ... Journal of Neuroscience 26 (37), 9448-9461, 2006 | 148 | 2006 |
| Time course of striatal ΔFosB‐like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment M Andersson, JE Westin, MA Cenci European journal of neuroscience 17 (3), 661-666, 2003 | 102 | 2003 |
| Automated gait analysis in bilateral Parkinsonian rats and the role of L-DOPA therapy JE Westin, MLF Janssen, TN Sager, Y Temel Behavioural brain research 226 (2), 519-528, 2012 | 45 | 2012 |
| Intracellular signaling and cellular plasticity in a rat model of L-DOPA-induced dyskinesia J Westin Lund University, 2006 | 1 | 2006 |
| EndothelialProliferationandIncreasedBlood–BrainBarrier PermeabilityintheBasalGangliainaRatModelof 3, 4-Dihydroxyphenyl-L-Alanine-InducedDyskinesia JE Westin, HS Lindgren, J Gardi, JR Nyengaard, P Brundin, P Mohapel, ... | | 2006 |
